TY  - BOOK
AU  - Jacquet,Laurie Rachet
AU  -  Toulemon,Léa
AU  -  Raimond,Véronique
AU  -  Degrassat-Théas,Albane
AU  -  Rochaix,Lise
AU  -  Paubel,Pascal
TI  - Drug prices in France: Summary of the recent developments in the French pricing system
PY  - 2018///.
							
N1  - 46
N2  - This article presents the different aspects of determining the price of reimbursable medicines in France. We discuss how drug prices are set according to drug status : in commercial distribution (brand-name and generic drugs) and in hospital distribution ( liste de retrocession [retrocession list] and liste en sus [supplementary list]). Pricing issues and other recent developments are discussed, as well as the role of relevant institutions such as the Healthcare Products Pricing Committee (CEPS) and the French National Authority for Health (HAS)
UR  - https://shs.cairn.info/journal-revue-francaise-des-affaires-sociales-2018-3-page-47?lang=en&redirect-ssocas=7080
ER  -